🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs
7,238

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Page 42 of 151

  1. Datopotamab deruxtecan

    AstraZeneca AB

    Locally Advanced Inoperable or Metastatic Breast Cancer Refractory to Endocrine Therapy

    phase 2 small molecule active

    1 trial

  2. Daunorubicin

    Hospital Authority, Hong Kong

    Down Syndrome

    phase 2 small molecule active

    1 trial

  3. Daxdilimab

    Amgen

    Lupus Nephritis

    phase 2 small molecule terminated

    1 trial

  4. Dazostinag

    Takeda

    Solid Neoplasms

    phase 2 small molecule completed

    1 trial

  5. Dazucorilant 300 mg

    CORCEPT THERAPEUTICS INC

    Amyotrophic Lateral Sclerosis

    phase 2 small molecule active

    1 trial

  6. Debio 4228, Debio 4228

    Alphapharm Pty Ltd

    advanced prostate cancer

    phase 2 small molecule active

    1 trial

  7. Decitabine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    AML

    phase 2 small molecule terminated

    1 trial

  8. Decitabine

    Teva Pharma GmbH

    Acute Myeloid Leukemia

    phase 2 small molecule completed

    1 trial

  9. Decitabine

    Shanghai Tong Ren Hospital

    Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  10. Decitabine

    CATALYST PHARMACEUTICALS, INC.

    Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  11. Decitabine

    The University of Hong Kong

    Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  12. Decitabine

    Karyopharm Therapeutics Inc

    Ovarian Cancer

    phase 2 small molecule active

    1 trial

  13. Decitabine/Tetrahydrouridine A 5/250 mg, Siklos 1 000 mg film-coated tablet., Placebo (NDec)

    NovoThirteen

    Sickle cell disease

    phase 2 small molecule active

    1 trial

  14. Decoy20

    BRIGHT MINDS BIOSCIENCES INC.

    Solid Tumor, Adult

    phase 2 small molecule active

    1 trial

  15. Dectova 10 mg/mL solution for infusion

    GlaxoSmithKline

    Influenza, Human

    phase 2 small molecule active

    1 trial

  16. Deep-sea fish oil

    The First People's Hospital of Lianyungang

    Radiation Toxicity

    phase 2 small molecule active

    1 trial

  17. Deferasirox

    Novartis Pharmaceuticals

    Myelodysplastic Syndromes

    phase 2 small molecule completed

    1 trial

  18. Deferasirox granule formulation

    Novartis Pharmaceuticals

    Transfusion-dependent Anemia

    phase 2 small molecule completed

    1 trial

  19. Defibrotide

    Jazz Pharmaceuticals Ireland Limited

    Graft-versus-host Disease

    phase 2 small molecule completed

    1 trial

  20. Defibrotide

    Jazz Pharmaceuticals Ireland Limited

    Covid19

    phase 2 small molecule active

    1 trial

  21. Defibrotide

    Jazz Pharmaceuticals Ireland Limited

    Transplant-Associated Thrombotic Microangiopathy

    phase 2 small molecule terminated

    1 trial

  22. Defibrotide

    Jazz Pharmaceuticals Ireland Limited

    DLBCL

    phase 2 small molecule terminated

    1 trial

  23. Defosbarasertib, IMFINZI 50 mg/mL concentrate for solution for infusion.

    AstraZeneca AB

    First-line patients with extensive disease small-cell lung cancer (SCLC)

    phase 2 small molecule active

    1 trial

  24. Degarelix

    Regeneron UK Limited

    Prostate Cancer

    phase 2 small molecule active

    1 trial

  25. Delamanid

    Otsuka Beijing Research Institute

    Tuberculosis, Multidrug-Resistant

    phase 2 small molecule completed

    1 trial

  26. Delamanid

    Otsuka Beijing Research Institute

    Multidrug Resistant Tuberculosis

    phase 2 small molecule completed

    1 trial

  27. Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS)

    BRIGHT MINDS BIOSCIENCES INC.

    Pulmonary Tuberculosis

    phase 2 small molecule terminated

    1 trial

  28. Delandistrogene moxeparvovec-rokl

    Hoffmann-La Roche

    Duchenne Muscular Dystrophy

    phase 2 small molecule active

    1 trial

  29. Delayed Release 6 mercaptopurine

    Teva Pharma GmbH

    Crohn's Disease

    phase 2 small molecule terminated

    1 trial

  30. Delayed Release 6MP or Calcitriol vs. Purinethol

    Teva Pharma GmbH

    Crohn's Disease

    phase 2 small molecule completed

    1 trial

  31. Delgocitinib cream, Cream Vehicle

    LEO Pharma A/S

    Mild to severe palmoplantar pustulosis

    phase 2 small molecule active

    1 trial

  32. Demcizumab

    Mereo BioPharma Group plc

    Pancreatic Cancer

    phase 2 small molecule completed

    2 trials

  33. Dendritic Cell Vaccination

    Quantum Biopharma

    Breast Cancer

    phase 2 mab active

    1 trial

  34. Dendritic Cell/Tumor Fusion Vaccine

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 mab terminated

    1 trial

  35. Denosumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer

    phase 2 small molecule active

    1 trial

  36. Dental stent

    Hospital Authority, Hong Kong

    Nasopharyngeal Carcinoma

    phase 2 other active

    1 trial

  37. DepoTXA

    Pacira Ireland Limited

    Total Knee Arthroplasty

    phase 2 small molecule terminated

    1 trial

  38. Deramiocel (CAP-1002)

    CAPRICOR THERAPEUTICS, INC.

    Duchenne Muscular Dystrophy

    phase 2 mab active

    1 trial

  39. Derazantinib

    Basilea Pharmaceutica

    Gastric Adenocarcinoma

    phase 2 small molecule terminated

    1 trial

  40. Dermatophagoides Farinae Drops Group 1

    The First People's Hospital of Lianyungang

    Atopic Dermatitis

    phase 2 mab completed

    1 trial

  41. Descartes 08

    Cartesian Therapeutics

    Myeloma Multiple

    phase 2 mab terminated

    1 trial

  42. Descartes-08

    Cartesian Therapeutics

    Systemic Lupus Erythematosus (SLE)

    phase 2 small molecule active

    1 trial

  43. Descartes-08

    Cartesian Therapeutics

    Myasthenia Gravis, Generalized

    phase 2 small molecule active

    1 trial

  44. Descartes-08

    Cartesian Therapeutics

    Childhood-onset Systemic Lupus Erythematous

    phase 2 small molecule active

    1 trial

  45. Descartes-08

    Cartesian Therapeutics

    Antisynthetase Syndrome

    phase 2 small molecule active

    1 trial

  46. Descartes-11

    Cartesian Therapeutics

    Multiple Myeloma

    phase 2 mab terminated

    2 trials

  47. Description and Composition of the Placebo • Placebo oil solution matching the Cannabis Extract Avextra 10/10 Solution. • Pharmaceutical form: solution (oil) • Route of administration: oral • Storage: Store tightly closed below 25°C and protected from light like the verum form. • Country of origin: Italy., Cannabis Extract Avextra 10/10 Solution

    Fondazione Telethon ETS

    Patients with advanced oncologic disease receiving active treatment with WHO level II or III opioids and adjuvants therapies

    phase 2 small molecule active

    1 trial

  48. Desipramine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 2 small molecule completed

    3 trials

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.